What caused the TMD.TO stock surge pre-market?

The pre-market surge appears driven by a volume spike and price gap from **C$0.05** to **C$1.125**. No formal press release was posted at the time. Traders should check Titan Medical’s investor site for filings and watch if volume holds above **100k** to confirm momentum.

How risky is investing in TMD.TO stock right now?

TMD.TO is high risk due to low float, early-stage product development and volatile intraday moves. Key risks include clinical, regulatory and funding outcomes. Use strict position limits and verify news before trading.

What is Meyka AI’s view on TMD.TO stock price direction?

Meyka AI rates TMD.TO **68.54/100 (B, HOLD)** and projects a 12-month target of **C$0.90**, implying **-20.00%** from **C$1.125**. These are model projections and not guarantees; monitor catalysts and volume confirmation.

Which metrics should traders monitor for TMD.TO stock?

Monitor volume versus average (**117,220** vs **45,936**), bid-ask spreads, official company updates, cash per share (**C$0.0667**), and any clinical or regulatory announcements tied to the Enos system.

CA Stocks

High-volume surge lifts TMD.TO Titan Medical Inc. (TSX) pre-market 13 Feb 2026: monitor liquidity

ByHuzaifa Zahoor February 13, 2026

TMD.TO stock opened the pre-market session sharply higher after a large volume spike, climbing to C$1.125 from an open of C$0.05 on 13 Feb 2026. Volume at 117,220 shares is more than double the average daily volume of 45,936, flagging the name as a high-volume mover. We review price action, liquidity, key ratios and the likely drivers behind the move, and explain what traders should watch next for Titan Medical Inc. (TSX) in Canada.